Apex Biotechnology Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 608.11 million compared to TWD 484.49 million a year ago. Net income was TWD 29.06 million compared to TWD 22.47 million a year ago. Basic earnings per share from continuing operations was TWD 0.29 compared to TWD 0.23 a year ago. Diluted earnings per share from continuing operations was TWD 0.29 compared to TWD 0.21 a year ago.
For the six months, sales was TWD 1,130.06 million compared to TWD 1,060.87 million a year ago. Net income was TWD 74.65 million compared to TWD 56.63 million a year ago. Basic earnings per share from continuing operations was TWD 0.75 compared to TWD 0.57 a year ago. Diluted earnings per share from continuing operations was TWD 0.74 compared to TWD 0.53 a year ago.